TotalMarketCap

Journey Medical

DERMNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$121.224 M

$4.30 -9.20%

Close of 6 Nov 2026

As of 6 Nov 2026, Journey Medical (DERM) has a market capitalization of $121.2M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$61.9M

#2648 by revenue

Earnings

-$11.4M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #277Spruce BiosciencesSPRB$122.4M
  2. #278Akebia TherapeuticsAKBA$121.3M
  3. #279Journey MedicalDERM$121.2M
  4. #280BGM GroupBGM$118.9M
  5. #281NkartaNKTX$114.2M

What if Journey Medical were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,000,442

Per share 232,932× higher

Bitcoin $1.53T

$54,132.18

Per share 12,604× higher

Apple $5.02T

$177,710.90

Per share 41,376× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Journey Medical are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.